AnaptysBio, Inc. ANAB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $238.2M+93.5% | $123.08M+242% | $35.97M-49.6% | $71.31M-85.6% | ||
| $73.44M-72.0% | $262.29M-26.1% | $354.94M-4.1% | $369.93M+606% | ||
| $33.85M-17.0% | $40.77M+495% | $6.85M+383% | $1.42M+62.0% | ||
| $4.76M-17.0% | $5.74M-36.8% | $9.08M+99.8% | $4.55M-7.3% | ||
| $350.25M-18.9% | $431.88M+6.2% | $406.84M-9.0% | $447.21M-19.3% | ||
| $1.37M-25.9% | $1.85M-11.9% | $2.1M+0.4% | $2.09M-8.5% | ||
| $12.52M-13.0% | $14.38M-11.1% | $16.17M-9.6% | $17.9M-8.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $364.4M-24.7% | $483.83M+7.0% | $452.39M-25.9% | $610.38M-5.1% | ||
| $3.87M-3.3% | $4M-14.8% | $4.7M+68.8% | $2.78M+59.9% | ||
| $32.67M-17.3% | $39.5M+27.6% | $30.97M+43.1% | $21.63M+68.3% | ||
| $2.08M+8.1% | $1.93M+8.3% | $1.78M+8.6% | $1.64M+8.8% | ||
| $38.63M-15.0% | $45.43M+21.3% | $37.44M+43.7% | $26.05M+61.8% | ||
| $12.03M-14.7% | $14.11M-12.0% | $16.04M-10.0% | $17.81M-8.4% | ||
| $14.11K-99.9% | $16.04M-10.0% | $17.81M-8.4% | $19.45M-7.2% | ||
| $0— | $0— | $0— | $0— | ||
| $28K-6.7% | $30K+11.1% | $27K-6.9% | $29K+3.6% | ||
| $809.77M-2.4% | $829.86M+18.1% | $702.97M-2.1% | $717.8M+5.8% | ||
| -$772.56M-1.7% | -$759.33M-23.6% | -$614.1M-36.3% | -$450.48M-40.0% | ||
| -$24K-108% | $305K+138% | -$797K+84.8% | -$5.25M-1,143% | ||
| $37.21M-47.5% | $70.87M-19.6% | $88.1M-66.4% | $262.1M-26.5% | ||
| $364.4M-24.7% | $483.83M+7.0% | $452.39M-25.9% | $610.38M-5.1% | ||
| $73.44M-72.0% | $262.29M-26.1% | $354.94M-4.1% | $369.93M+606% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.52M-13.0% | $14.38M-11.1% | $16.17M-9.6% | $17.9M-8.5% | ||
| $12.52M-13.0% | $14.38M-11.1% | $16.17M-9.6% | $17.9M-8.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.52M-13.0% | $14.38M-11.1% | $16.17M-9.6% | $17.9M-8.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $32.67M-17.3% | $39.5M+27.6% | $30.97M+43.1% | $21.63M+68.3% | ||
| $32.67M-17.3% | $39.5M+27.6% | $30.97M+43.1% | $21.63M+68.3% | ||
| $14.11K-99.9% | $16.04M-10.0% | $17.81M-8.4% | $19.45M-7.2% | ||
| $28K-6.7% | $30K+11.1% | $27K-6.9% | $29K+3.6% | ||
| $0— | $0— | $0— | $0— | ||
| $276.53M-21.8% | $353.43M+13.7% | $310.81M+2.1% | $304.41M+21.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can AnaptysBio, Inc. cover its short-term obligations?
- Its current ratio is 7.58 — current assets exceed current liabilities.
- Where does AnaptysBio, Inc.'s balance sheet data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.